The study found that semaglutide significantly reduced weekly alcohol craving (, 0.39)
"Representan un nuevo captulo en el cambio conceptual gradual sobre cmo la sociedad aborda la obesidad, de ser una 'condicin de estilo de vida' a una enfermedad crnica compleja, prevenible y tratable"
In SURMOUNT-1, published in NEJM in 2022, tirzepatide at the 15 mg weekly dose produced a mean placebo-adjusted body weight reduction of 17.8% at 72 weeks in adults with obesity (Jastreboff et al., NEJM, 2022)
But as a nutrition coach, here's what I look for when I'm recommending recipes to my clients on these medications: High protein per serving (25g+) to protect muscle mass and keep you satiated longer
Legacy PBMs leverage formularies and rebates, inflate prices, retain rebates via hidden fees, and shift costs to employers and patients
Regulation of adult neurogenesis by antidepressant treatment